These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 27640728)
21. CRISPR technologies for bacterial systems: Current achievements and future directions. Choi KR; Lee SY Biotechnol Adv; 2016 Nov; 34(7):1180-1209. PubMed ID: 27566508 [TBL] [Abstract][Full Text] [Related]
22. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy. Zhang X; Wang L; Liu M; Li D Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255 [TBL] [Abstract][Full Text] [Related]
23. A Transgenic Core Facility's Experience in Genome Editing Revolution. Yuan CL; Hu YC Adv Exp Med Biol; 2017; 1016():75-90. PubMed ID: 29130154 [TBL] [Abstract][Full Text] [Related]
24. Identification of genomic sites for CRISPR/Cas9-based genome editing in the Vitis vinifera genome. Wang Y; Liu X; Ren C; Zhong GY; Yang L; Li S; Liang Z BMC Plant Biol; 2016 Apr; 16():96. PubMed ID: 27098585 [TBL] [Abstract][Full Text] [Related]
25. Current status of potential applications of repurposed Cas9 for structural and functional genomics of plants. Seth K; Harish Biochem Biophys Res Commun; 2016 Nov; 480(4):499-507. PubMed ID: 27955725 [TBL] [Abstract][Full Text] [Related]
26. Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research. Aquino-Jarquin G Cancer Res; 2017 Dec; 77(24):6812-6817. PubMed ID: 29208606 [TBL] [Abstract][Full Text] [Related]
27. Diagnosis and therapy with CRISPR advanced CRISPR based tools for point of care diagnostics and early therapies. Uppada V; Gokara M; Rasineni GK Gene; 2018 May; 656():22-29. PubMed ID: 29496558 [TBL] [Abstract][Full Text] [Related]
29. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium. Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775 [TBL] [Abstract][Full Text] [Related]
30. Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9. Feng Y; Chen C; Han Y; Chen Z; Lu X; Liang F; Li S; Qin W; Lin S G3 (Bethesda); 2016 Aug; 6(8):2517-21. PubMed ID: 27317783 [TBL] [Abstract][Full Text] [Related]
31. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish. Hruscha A; Krawitz P; Rechenberg A; Heinrich V; Hecht J; Haass C; Schmid B Development; 2013 Dec; 140(24):4982-7. PubMed ID: 24257628 [TBL] [Abstract][Full Text] [Related]
32. Development of a genome editing technique using the CRISPR/Cas9 system in the industrial filamentous fungus Aspergillus oryzae. Katayama T; Tanaka Y; Okabe T; Nakamura H; Fujii W; Kitamoto K; Maruyama J Biotechnol Lett; 2016 Apr; 38(4):637-42. PubMed ID: 26687199 [TBL] [Abstract][Full Text] [Related]
33. Optimization of CRISPR/Cas9 genome editing to modify abiotic stress responses in plants. Osakabe Y; Watanabe T; Sugano SS; Ueta R; Ishihara R; Shinozaki K; Osakabe K Sci Rep; 2016 May; 6():26685. PubMed ID: 27226176 [TBL] [Abstract][Full Text] [Related]
34. CRISPR/Cas9-Mediated Genome Editing of Mouse Small Intestinal Organoids. Schwank G; Clevers H Methods Mol Biol; 2016; 1422():3-11. PubMed ID: 27246017 [TBL] [Abstract][Full Text] [Related]
35. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System. Altenbuchner J Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565 [TBL] [Abstract][Full Text] [Related]
36. Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9. Du H; Zeng X; Zhao M; Cui X; Wang Q; Yang H; Cheng H; Yu D J Biotechnol; 2016 Jan; 217():90-7. PubMed ID: 26603121 [TBL] [Abstract][Full Text] [Related]
37. Genome Editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 System. Wang S; Dong S; Wang P; Tao Y; Wang Y Appl Environ Microbiol; 2017 May; 83(10):. PubMed ID: 28258147 [No Abstract] [Full Text] [Related]